Relative bioavailability of delamanid 50 mg tablets dispersed in water in healthy adult volunteers.
Sign Up to like & getrecommendations! Published in 2023 at "British journal of clinical pharmacology"
DOI: 10.1111/bcp.15672
Abstract: AIM Delamanid is a novel drug to treat of drug-resistant tuberculosis, manufactured as 50 mg solid and 25 mg dispersible tablets. We evaluated the effects of dispersing the 50 mg tablet, focusing on the relative… read more here.
Keywords: relative bioavailability; healthy adult; delamanid tablets; bioavailability ... See more keywords